Methyl-β-cyclodextrin concurs with interleukin (IL)-4, IL-13 and IL-25 to induce alterations reminiscent of atopic dermatitis in reconstructed human epidermis

Exp Dermatol. 2018 Apr;27(4):435-437. doi: 10.1111/exd.13113. Epub 2016 Dec 15.
No abstract available

Keywords: atopic dermatitis; epidermal barrier and methyl-β-cyclodextrin; interleukins; reconstructed human epidermis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbonic Anhydrase II / genetics
  • Carbonic Anhydrase II / metabolism
  • Cytokines / metabolism
  • Dermatitis, Atopic / chemically induced
  • Epidermis / pathology
  • Epidermis / physiopathology*
  • Filaggrin Proteins
  • Gene Expression / drug effects
  • Humans
  • Hyaluronan Synthases / metabolism
  • Hyaluronic Acid / metabolism
  • Interleukin-13 / pharmacology
  • Interleukin-17 / pharmacology
  • Interleukin-4 / pharmacology
  • Interleukins / pharmacology*
  • Intermediate Filament Proteins / genetics
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Nerve Tissue Proteins / genetics
  • Skin Physiological Phenomena / drug effects*
  • Thymic Stromal Lymphopoietin
  • beta-Cyclodextrins / pharmacology*

Substances

  • Cytokines
  • Filaggrin Proteins
  • IL13 protein, human
  • IL25 protein, human
  • IL4 protein, human
  • Interleukin-13
  • Interleukin-17
  • Interleukins
  • Intermediate Filament Proteins
  • Membrane Proteins
  • NELL2 protein, human
  • Nerve Tissue Proteins
  • beta-Cyclodextrins
  • loricrin
  • methyl-beta-cyclodextrin
  • Interleukin-4
  • Hyaluronic Acid
  • Hyaluronan Synthases
  • Carbonic Anhydrase II
  • Thymic Stromal Lymphopoietin